- Strategic investments in advanced cellular agriculture technologies position CULT as a leader in the emerging sustainable food market.
- Well-prepared to capitalize on the growing cultivated meat sector, supported by significant investments and regulatory advancements.
- Driving global food system transformation by fostering innovation and promoting ethical, sustainable food production.
August has been an incredibly busy month for CULT Food, which is one of the reasons I’m such a strong supporter of the company. What stands out to me is CULT’s rapid progress and forward momentum. Some might point out that while the company experienced a meteoric rise, its stock price has since dipped. That’s true, but CULT Food (CSE:CULT, OTC:CULTF, FRA:LN0) still has significant potential for future gains. In this article, I’ll explain why you should consider taking a closer look at CULT and highlight the key achievements the company has made this month.
About CULT Food
What really excites me about CULT Food Science is their mission to revolutionize the food industry with a focus on global well-being. They’re not just developing brands; they’re investing in cutting-edge cellular agriculture companies around the world. With a venture portfolio that spans four continents and includes 18 early-stage investments, CULT is at the forefront of some of the most promising and diverse innovations in this space.
What I admire most is CULT’s dedication to sourcing the best ingredients. They actively seek out companies using cellular agriculture to produce sustainable, slaughter-free, and nutritionally rich food. When they find these gems, CULT invests, securing equity stakes and forming strategic partnerships to ensure a reliable supply of these high-quality ingredients.
Why is investing in CULT a dive into a massive market opportunity? The answer lies in the explosive potential of the cultivated meat sector. According to a McKinsey report, this industry could be valued at $25 billion within the next decade. What’s exciting is how rapidly things are progressing—production costs have dropped by 99% since the first prototypes. Imagine, in late 2020, diners in Singapore, the first country to approve cultivated meat, enjoyed crispy sesame chicken made from animal cells.
In the U.S., the regulatory landscape is shaping up to support this revolutionary product, while the EU is pouring significant funds into further research. Despite being in its infancy, with fewer than 100 startups, the industry attracted around $350 million in 2020 and about $250 million in 2021. This wave of investment includes contributions from major animal-protein firms like Tyson and Nutreco, along with high-profile investors such as Temasek and SoftBank.
And it doesn’t stop there. A Jeff Bezos-backed fund granted $30 million to N.C. State for lab-grown protein research, the USDA has approved lab-grown meat for sale in the U.S., and Brazil’s JBS is building a lab-grown beef facility in Spain. Even Bill Gates and Richard Branson are championing lab-grown meat as the future of food. With all this momentum, CULT is positioned to tap into an extraordinary market opportunity.
Recent News Releases (August)
August 22
De Novo Foodlabs has just secured a $1.5M seed investment from Joyful Ventures, a major step forward in bringing their groundbreaking precision-fermented lactoferrin product, NanoFerrin™, to market.
Here are the key takeaways:
- De Novo Foodlabs has raised a total of $4M, with this latest $1.5M coming from Joyful Ventures, a fund that launched in 2023 with $23M from leaders in the alternative protein industry. The fund is spearheaded by industry trailblazers like Jennifer Stojkovic of Vegan Women Summit, Milo Runkle from Good Food Institute, and Blaine Vess of Student Brands. Advisors and investors include influential figures such as Oatly co-founder Björn Öste and Shiok Meats co-founder Sandhya Sriram.
- This fresh capital will accelerate the commercialization of NanoFerrin™, an animal-free alternative to bovine lactoferrin, right here in the U.S. What makes NanoFerrin™ so exciting is that it offers all the health benefits—like enhanced immunity and longevity—without the ethical and sustainability issues tied to traditional lactoferrin production.
“De Novo’s success is a testament to their leadership in the functional nutrition space. Their precision-fermented NanoFerrin™ protein has the potential to transform how we approach health and nutrition, offering a scalable, ethical alternative to traditional animal-derived proteins. This progress not only underscores De Novo’s innovation but also adds value to CULT’s venture portfolio as we continue to support game-changing advancements in food technology.”
Mitchell Scott, CEO of CULT Food Science,
August 8
The company’s subsidiary, Further Foods Inc., has just reached a significant milestone by completing and submitting the feeding trial design protocol for their innovative dog food products containing cell-cultivated chicken to the FDA.
Here are the key takeaways:
- Further Foods has officially submitted the protocol for its groundbreaking feeding trial, which will scientifically validate the use of cultivated chicken in dog food products. If all goes well, they plan to start the feeding trials in Q4 2024, pending FDA approval.
- The company is working closely with renowned vet nutritionist Dr. Sarah Dodd to ensure that every aspect of the trial meets the highest standards of safety and nutritional efficacy.
- This feeding trial is a critical step towards bringing Noochies! cultivated meat pet food products to pet owners across North America, ensuring they’re both safe and effective for our furry friends.
“Completing and submitting the feeding trial design to the FDA is a critical step towards bringing cultivated meat to the pet food market. A successful trial could significantly change the landscape of pet food, offering nutritional, environmental, and ethical benefits for pet owners. We are excited to be at the forefront of this innovation and look forward to advancing this trial in collaboration with Dr. Sarah Dodd and the FDA.
Mitchell Scott, CEO of CULT Food Science
Conclusion
In conclusion, CULT Food (CSE:CULT, OTC:CULTF, FRA:LN0) is strategically positioned as a leader in the evolving food industry, focusing on sustainable and ethical innovation. Through targeted investments in cellular agriculture and a commitment to sourcing high-quality ingredients, CULT is at the forefront of a market with significant growth potential. The achievements of De Novo Foodlabs and Further Foods underscore CULT’s ability to foster pioneering technologies that can reshape global food systems.
As the cultivated meat sector continues to expand, supported by increasing investments and regulatory developments, CULT Food (CSE:CULT, OTC:CULTF, FRA:LN0) is well-prepared to capitalize on these advancements. With its strong portfolio and forward-looking strategy, CULT is set to play a pivotal role in the future of food production.
Posted on Behalf of Cult Food Sciences
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.
